cnbc semaglutide India's obesity and diabetes drug market is on the verge of taking off. Semaglutide, the molecule behind Ozempic and Wegovy will go off patent this Saturday paving the way for low-cost generic drugs Novo Nordisk’s latest obesity drug

It's very exciting to have, especially since it's more of a noninvasive strategy compared to bariatric surgery, and a lot more patients will be open to it.

It's time to get it into the fridge

Lana Rodriguez, 37, started taking semaglutide as a weekly injection in September 2022 after years of binge eating and weight cycling

(2024) Effect of N acetyl cysteine in children with metabolic dysfunctionassociated steatotic liver diseaseA pilot study

Pair fiber intake with adequate hydration: aim for 2.53 liters of water daily, as fiber without sufficient fluid can paradoxically worsen constipation in some users

Additionally, lifestyle factors like obesity, smoking, and wearing tight clothing can exacerbate the condition